Concentric Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $732K | Sell |
25,298
-568
| -2% | -$16.6K | 0.18% | 84 |
|
|
2024
Q2 | $724K | Sell |
25,866
-160
| -0.6% | -$4.41K | 0.19% | 84 |
|
|
2024
Q1 | $722K | Sell |
26,026
-7,415
| -22% | -$206K | 0.19% | 84 |
|
|
2023
Q4 | $963K | Sell |
33,441
-9,491
| -22% | -$287K | 0.28% | 71 |
|
|
2023
Q3 | $1.42M | Sell |
42,932
-1,050
| -2% | -$37.1K | 0.47% | 64 |
|
|
2023
Q2 | $1.61M | Sell |
43,982
-2,331
| -5% | -$90.7K | 0.51% | 63 |
|
|
2023
Q1 | $1.89M | Sell |
46,313
-550
| -1% | -$23.8K | 0.63% | 59 |
|
|
2022
Q4 | $2.4M | Sell |
46,863
-986
| -2% | -$47.3K | 0.82% | 51 |
|
|
2022
Q3 | $2.09M | Sell |
47,849
-807
| -2% | -$39.2K | 0.77% | 53 |
|
|
2022
Q2 | $2.55M | Sell |
48,656
-3,288
| -6% | -$168K | 0.86% | 48 |
|
|
2022
Q1 | $2.69M | Buy |
51,944
+87
| +0.2% | +$4.51K | 0.78% | 52 |
|
|
2021
Q4 | $3.06M | Sell |
51,857
-785
| -1% | -$38.9K | 0.86% | 48 |
|
|
2021
Q3 | $2.26M | Sell |
52,642
-725
| -1% | -$32.1K | 0.69% | 59 |
|
|
2021
Q2 | $2.09M | Sell |
53,367
-1,000
| -2% | -$38.9K | 0.64% | 61 |
|
|
2021
Q1 | $1.97M | Buy |
54,367
+593
| +1% | +$21.1K | 0.65% | 61 |
|
|
2020
Q4 | $1.98M | Sell |
53,774
-3,110
| -5% | -$114K | 0.73% | 60 |
|
|
2020
Q3 | $1.98M | Buy |
56,884
+4
| +0% | +$140 | 0.85% | 47 |
|
|
2020
Q2 | $1.76M | Sell |
56,880
-3,253
| -5% | -$111K | 0.83% | 49 |
|
|
2020
Q1 | $1.86M | Sell |
60,133
-944
| -2% | -$32.2K | 1.03% | 39 |
|
|
2019
Q4 | $2.27M | Buy |
61,077
+34,889
| +133% | +$1.24M | 0.97% | 40 |
|
|
2019
Q3 | $893K | Buy |
26,188
+28
| +0.1% | +$1.02K | 0.57% | 54 |
|
|
2019
Q2 | $1.07M | Buy |
26,160
+23
| +0.1% | +$913 | 0.7% | 53 |
|
|
2019
Q1 | $1.05M | Buy |
26,137
+3,184
| +14% | +$128K | 0.71% | 53 |
|
|
2018
Q4 | $951K | Sell |
22,953
-1,060
| -4% | -$44K | 0.73% | 52 |
|
|
2018
Q3 | $1M | Sell |
24,013
-135
| -0.6% | -$5.2K | 0.7% | 55 |
|
|
2018
Q2 | $831K | Buy |
24,148
+25
| +0.1% | +$854 | 0.6% | 58 |
|
|
2018
Q1 | $812K | Sell |
24,123
-1,291
| -5% | -$44.4K | 0.6% | 57 |
|
|
2017
Q4 | $873K | Sell |
25,414
-346
| -1% | -$11.8K | 0.63% | 57 |
|
|
2017
Q3 | $872K | Buy |
25,760
+27
| +0.1% | +$868 | 0.66% | 57 |
|
|
2017
Q2 | $820K | Buy |
25,733
+26
| +0.1% | +$820 | 0.65% | 58 |
|
|
2017
Q1 | $834K | Buy |
25,707
+25
| +0.1% | +$788 | 0.68% | 56 |
|
|
2016
Q4 | $791K | Buy |
+25,682
| New | +$784K | 0.66% | 56 |
|
Other funds holding PFE
Concentric Wealth Management's PFE Position: Q3 2024 in Review
Concentric Wealth Management reduced its Pfizer (PFE) stake by 2.2% in Q3 2024, selling an estimated $16.6K and leaving 25,298 shares worth $732K. The position accounts for 0.18% of the portfolio, ranked #84.
Concentric Wealth Management first reported a position in PFE in Q4 2016 and has held it in 32 quarters since. The position peaked at $3.06M in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Concentric Wealth Management held 25,298 shares of Pfizer worth $732K as of Q3 2024.
- Concentric Wealth Management sold 568 Pfizer shares in Q3 2024, an estimated $16.6K.
- Pfizer made up 0.18% of Concentric Wealth Management's portfolio in Q3 2024, its #84 holding.
- Concentric Wealth Management first reported a position in Pfizer in Q4 2016 and has held it in 32 quarters since.
- Concentric Wealth Management's Pfizer position peaked at $3.06M in Q4 2021.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Concentric Wealth Management's 13F filing for Q3 2024, filed 13 Nov 2024.